Manufacture of BNC101 Commences at Lonza

Bionomics Limited announced today that it has initiated manufacturing activities for BNC101, its lead anti-cancer stem cell candidate following completion of key preclinical studies.

http://www.globenewswire.com/news-release/2013/04/23/540431/10029540/en/Manufacture-of-BNC101-Commences-at-Lonza.html